Researchers have discovered a protein that is crucial to the operation of numerous novel cancer medicines. The discovery, according to the researchers, will probably help with efforts to optimize the use of immunotherapies against a number of difficult tumors.
For the first time, researchers have identified a distinct molecular mechanism underlying the early phases of programmed cell death, or apoptosis, a process that plays an important role in cancer prevention.
Apoptosis is essential for human life, and its disruption can cause cancerous cells to grow and not respond to cancer treatment. In healthy cells, it is regulated by two proteins with opposing roles known as Bax and Bcl-2.
The study was published in 'Science Advances'.
For the first time, scientists have described a special molecular mechanism of the early phases of programmed cell death, often known as apoptosis, a process that is essential in the prevention of cancer.
The removal of liver cells that have undergone apoptosis, in which cells are intended to die in a controlled manner, maybe the function of a type of white blood cell typically linked to immunological responses to foreign particles.